Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2596 AL 2610

Effects of an incentive spirometer versus a threshold inspiratory muscle trainer on lung functions in Parkinson's disease patients: a randomized trial

Mohammed Yusuf SF, Bhise A, Nuhmani S, Alghadir AH, Khan M.

Sci Rep. 2023 Feb 13;13(1):2516. doi: 10.1038/s41598-023-29534-8.

Voice improvement following conventional speech therapy combined with singing intervention in people with Parkinson's disease: A three-arm randomised controlled trial

Mohseni Z, Mohamadi R, Habibi SAH, Saffarian A, Abolghasemi J.

Int J Lang Commun Disord. 2023 Sep-Oct;58(5):1752-1767. doi: 10.1111/1460-6984.12900. Epub 2023 Jun 7.

Prevalence and Mortality Risk of Neurological Disorders during the COVID-19 Pandemic: An Umbrella Review of the Current Evidence

Park JM, Woo W, Lee SC, Park S, Yon DK, Lee SW, Smith L, Koyanagi A, Shin JI, Kim YW.

Neuroepidemiology. 2023;57(3):129-147. doi: 10.1159/000530536. Epub 2023 Apr 12.

Lisbon Intensive Falls Trampoline Training (LIFTT) Program for people with Parkinson's for balance, gait, and falls: study protocol for a randomized controlled trial

Domingos J, Dean J, Fernandes JB, Ramos C, Grunho M, Proença L, Vaz JR, Godinho C.

Trials. 2023 Feb 8;24(1):101. doi: 10.1186/s13063-023-07131-4.

Efficacy of a Flavored Lubricating Oral Spray on Medication Swallowing in Older Individuals

Kavalam P, Benkart C, Kim C, Kalinousky D, Parbuoni K, Cooke CE, Morgan JA.

Sr Care Pharm. 2023 Jun 1;38(6):252-257. doi: 10.4140/TCP.n.2023.252.

Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial

Jin ZH, Wang YX, Meng DT, Qin Y, Duan YN, Fang JP, Wang RD, Liu YJ, Liu C, Wang P, Yan HJ, Zhen Y, An X, Chen KK, Yu X, Lyu D, Yan XY, Fang BY.

Trials. 2023 Jun 16;24(1):410. doi: 10.1186/s13063-023-07425-7.

WITHDRAWN: Laterality and frequency settings of subthalamic nucleus DBS for Parkinson's disease: A systematic review and network meta-analysis

Dharnipragada R, Denduluri LS, Naik A, Bertogliat M, Awad M, Ikramuddin S, Park MC.

Parkinsonism Relat Disord. 2023 Jun 10:105455. doi: 10.1016/j.parkreldis.2023.105455. Online ahead of print.

Effect of Zishen pingchan granules combined with pramipexole on serum BDNF, IL-1β, IL-6, CRP, TNF-α levels in depressed patients with Parkinson's disease: Results of a randomized, double-blind, controlled study

Ning H, Zhou H, Yang N, Ren J, Wang H, Liu W, Zhao Y.

Exp Gerontol. 2023 Oct 15;182:112295. doi: 10.1016/j.exger.2023.112295. Epub 2023 Sep 20.

Parkinson's disease genome-wide association study-linked PARK16 variant is associated with a lower risk of cognitive impairment: A 4-year observational study

Xiao B, Deng X, Ng EY, Lo YL, Xu Z, Tay KY, Au WL, Ng A, Tan LCS, Tan EK.

Eur J Neurol. 2023 Sep;30(9):2874-2878. doi: 10.1111/ene.15893. Epub 2023 Jun 15.

Effects of high-intensity interval training and moderate-intensity continuous training on sarcopenia-related parameters in participants with Parkinson's disease: A 24-week randomized pilot trial substudy

Kim R, Choi S, Kang N, Park K, Shin H, Lee H, Lee H, Jun JS, Jeon B, Byun K.

Parkinsonism Relat Disord. 2023 Dec;117:105901. doi: 10.1016/j.parkreldis.2023.105901. Epub 2023 Oct 21.

Climb up! Head up! Climbing improves posture in Parkinson's disease. A secondary analysis from a randomized controlled trial

Langer A, Roth D, Santer A, Flotz A, Gruber J, Wizany L, Hasenauer S, Pokan R, Dabnichki P, Treven M, Zimmel S, Schmoeger M, Willinger U, Gassner L, Maetzler W, Zach H.

Clin Rehabil. 2023 Nov;37(11):1492-1500. doi: 10.1177/02692155231174990. Epub 2023 May 8.

Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool

Moes HR, Ten Kate JM, Portman AT, van Harten B, van Kesteren ME, Mondria T, Lunter G, Buskens E, van Laar T.

Parkinsonism Relat Disord. 2023 Apr;109:105359. doi: 10.1016/j.parkreldis.2023.105359. Epub 2023 Mar 8.

Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

Laurencin C, Timestit N, Marques A, Duchez DD, Giordana C, Meoni S, Huddlestone M, Danaila T, Anheim M, Klinger H, Vidal T, Fatisson M, Caire C, Nourredine M, Boulinguez P, Dhelens C, Ballanger B, Prange S, Bin S, Thobois S.

J Neurol. 2023 Oct;270(10):4851-4859. doi: 10.1007/s00415-023-11814-y. Epub 2023 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias